AL Sydbank A/S share buyback programme: transactions in week 39
Tweet
Share
E-mail
Company Announcement No 54/2026 | Peberlyk 4 6200 Aabenraa Denmark Tel +45 74 37 37 37 AL Sydbank A/S CVR No DK 12626509, Aabenraa al-sydbank.com |
| 28 September 2026 |
AL Sydbank A/S share buyback programme: transactions in week 39
On 25 February 2026 AL Sydbank A/S announced a share buyback programme of DKK 1,100m. The share buyback programme commenced on 2 March 2026 and will be completed by 31 January 2027.
The purpose of the share buyback programme is to reduce the share capital of AL Sydbank A/S and the programme is executed in compliance with the provisions of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 and Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, collectively referred to as the Safe Harbour rules.
The following transactions have been made under the share buyback programme:
| Number of shares | VWAP | Gross value (DKK) | |
| Accumulated, most recent Announcement | 1,214,000 | 684,533,310.00 | |
| 21 September 2026 22 September 2026 23 September 2026 24 September 2026 25 September 2026 | 7,000 6,000 6,000 6,000 7,000 | 713.94 708.91 707.49 704.82 719.13 | 4,997,580.00 4,253,460.00 4,244,940.00 4,228,920.00 5,033,910.00 |
| Total over week 39 | 32,000 | 22,758,810.00 | |
| Total accumulated during the share buyback programme | 1,246,000 | 707,292,120.00 |
All transactions were made under ISIN DK 0010311471 and effected by Danske Bank A/S on behalf of AL Sydbank A/S.
Further information about the transactions, cf Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council on market abuse and Commission delegated regulation, is available in the attachment.
Following the above transactions, AL Sydbank A/S holds a total of 1,246,709 own shares, equal to 1.45% of the Bank’s share capital.
Yours sincerely
AL Sydbank A/S
Attachment
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Draganfly Announces Strategic Investment from Unusual Machines and a Leading U.S. Investment Fund
- Predigy Inc. Submits for Company Approval to the Nevada Gaming Control Board for ‘Predigy Edge’ Binary Bet, Regulated, Prediction-Style Technology
- U.S. Food and Drug Administration Awards Additional Funding for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Stock BuybackSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
